Clinical Trials Browser

Recruiting × Saline Solution × 90 days × Clear all

Agammaglobulinemia, Bacterial Infections, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell

NCT06888921 2026-04-01

MAIA-ovarian

Phase 1/2 Recruiting

60 enrolled

Gynecologic

Ovarian Neoplasms

NCT06807437 2026-03-31

Lanreotide Versus Placebo Before Surgery to Prevent a Surgical Complication Called a Pancreatic Fistula

Phase 3 Recruiting

274 enrolled

Gastrointestinal

Pancreatic Neoplasms

NCT05072314 2026-03-25

LOLIPOP

Phase 3 Recruiting

4,300 enrolled

Breast

Breast Neoplasms, Pain, Postoperative

NCT06229483 2026-03-19

The Effects of Intraoperative Tranexamic Acid on Perioperative Bleeding In Craniotomies

Phase 3 Recruiting

102 enrolled

CNS

Brain Neoplasms, Hemorrhage

NCT07246863 2026-03-04

Trial Investigating Visugromab and Nivolumab With or Without Docetaxel in 2L Treatment of Participants With Metastatic NSCLC

Phase 2 Recruiting

131 enrolled

Other solid neoplasmThoracic

Metastatic Non-Squamous Non-Small Cell Lung Cancer

NCT05029726 2026-02-17

Regional Anesthesia in Minimally Invasive Lumbar Spine Surgery

Phase 4 Recruiting

125 enrolled

Intervertebral Disc Displacement, Radiculopathy, Spinal Stenosis, Spondylolisthesis, Synovial Cyst, Spondylosis, Intervertebral Disc Degeneration

NCT05849129 2026-01-23

AIVAA

Phase 2 Recruiting

90 enrolled

Thoracic

Lung Neoplasms

Clinical Trials

EXCELL

MAIA-ovarian

Lanreotide Versus Placebo Before Surgery to Prevent a Surgical Complication Called a Pancreatic Fistula

LOLIPOP

The Effects of Intraoperative Tranexamic Acid on Perioperative Bleeding In Craniotomies

Trial Investigating Visugromab and Nivolumab With or Without Docetaxel in 2L Treatment of Participants With Metastatic NSCLC

Regional Anesthesia in Minimally Invasive Lumbar Spine Surgery

AIVAA